Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.19 | 0.0002 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |